Oncology CME

Credits: 1.00 CME
The Medical College of Wisconsin
Innovative Therapeutic Concepts for ASCT-Eligible Patients With Myeloma: Advancing Toward More Effective Care Across Treatment Settings
Sagar Lonial, MD, FACP
10 April, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Attacking the Clinical Problem of VOD/SOS in HCT Recipients: Insights on Pathophysiology, Diagnosis, and Treatment
Mitchell Cairo, MD
3 April, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Harnessing Recent Advances in CAR-T Cell Therapy for Leukemia and Lymphoma in the Era of Stem Cell Transplantation
Tanya Siddiqi, MD / Shannon L. Maude, MD, PhD
2 April, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Integrating Innovative Therapeutics With Allogeneic HCT in AML: Insights and Evidence From Induction to Maintenance
Alexander Perl, MD / James M. Foran, MD, FRCPC
29 March, 2019
Credits: 1.00 CME / MOC / CNE
Medical Learning Institute, Inc.
Rheumatology, Immunology, and Immuno-Oncology Intersect: Navigating the Complexities of Immune Checkpoint Inhibition, Autoimmunity, and Immune-Related Adverse Events
Leonard Calabrese, DO
29 March, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Innovative Therapies in Post-Transplant GVHD: Personal Insights From the Patient CaseBook
Madan Jagasia, MBBS, MS, MMHC
28 March, 2019
Credits: 1.00 MOC / CME / CNE
Medical Learning Institute, Inc.
Expanding Options and Difficult Choices in the Initial Treatment of Advanced NSCLC: How to Personalize Treatment Decisions in the Era of Immuno-Oncology and Combinations
Mark Socinski, MD
27 March, 2019
Credits: 1.50 CME
Purdue University College of Pharmacy
Unraveling the Complexities of Prostate Cancer Management: Focus on Therapeutic Decisions for Early-Stage Disease and the Implications for Later-Stage Disease
Robert Dreicer, MD, MS, MACP, FASCO
26 March, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Managing CMV in the New Era of Antiviral Therapy: Practical Considerations in the HCT Setting
Roy Chemaly, MD, MPH, FIDSA, FACP
26 March, 2019
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Making Effective Therapeutic Choices for Advanced RCC in an Evolving Treatment Landscape: Personal Insights From the Patient CaseBook
David McDermott, MD
20 March, 2019
Credits: 0.50 CME
University of Nebraska Medical Center
Exploring Clinical Decisions in the New Era of Myeloma Management: The Impact of Novel Platforms and Agent Classes Across the Spectrum of Care
Luciano Costa, MD, PhD
13 March, 2019
Credits: 1.00 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Urgent Care of Patients Receiving Cancer Immunotherapy: Recognition and Management of Immune-Mediated Adverse Reactions in the ED
Evan Lipson, MD
22 February, 2019
Credits: 1.50 CME
Medical Learning Institute, Inc.
Breaking the Paradox: Expanding Options and New Questions in HCC Management—Mapping the Pathways to Better Patient Outcomes
Richard Finn, MD
15 February, 2019
Credits: 1.00 CME / CNE
Penn State College of Medicine / Medical Learning Institute, Inc.
Building Innovative Treatment Options for Patients With B-Cell Malignancies: Practical Insights on Clinical Evidence and Integration Strategies
Nathan Fowler, MD
15 February, 2019
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
The TRK to Tumor-Agnostic Care in Solid Tumors: A Pathology-Focused Guide to the Clinical Role of TRK Fusions in Personalizing Cancer Therapy
Anna Farago, MD, PhD
7 February, 2019
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Molecular Testing for EGFR Mutations in the Context of a Changing Treatment Landscape, Evolving Testing Options, and Updated Guidelines: What Pathologists Need to Know and Do
Lynette Sholl, MD
6 February, 2019
Credits: 0.50 CME
Medical Learning Institute, Inc.
Progress in Developing Novel Treatment Options for PTCL: Expert Views on Integrating Innovative Therapeutics Into Care
Younes Anas, MD
29 January, 2019
Credits: 1.00 CME
Medical Learning Institute, Inc.
Keeping Pace With Immunotherapy Advances in Bladder Cancer: Tools for Winning the Race and Optimizing Patient Outcomes
Arjun Balar, MD
31 December, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
The Promise of New Concepts and Innovative Therapy in Advanced Sarcoma: From Established Targets to TRK Inhibition and Beyond
George Demetri, MD
27 December, 2018
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
The Central Role of Biomarker Testing in Piecing Together the Immuno-Oncology Puzzle: Essential Guidance for Pathologists to Maximize the Potential of Cancer Immunotherapies
Robert Anders, MD, PhD
27 December, 2018
Credits: 1.50 CME / MOC / CE / CPE
Medical Learning Institute, Inc.
Incorporating Cancer Immunotherapies Into the Oncology Treatment Arsenal in Managed Care Settings: Navigating the Complexities of Value Assessment & Cost Optimization in the Era of Immuno-Oncology
Michael Atkins, MD
24 December, 2018
Credits: 2.00 CME
Medical Learning Institute, Inc.
Exploring the Present and Future of BTK Inhibition in B-Cell Malignancies: Expert Insights on Practical Implications for Patient Management
Andre Goy, MD
21 December, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
Surveying the View From the Driver's Seat in Hepatocellular Carcinoma: Bringing Into Focus Hepatology's Key Role in Guiding HCC Care Down the Path to Improved Outcomes
Jorge Marrero, MD, MS
21 December, 2018
Credits: 1.00 CME / MOC / CE
Medical Learning Institute, Inc.
The Evolving Role of Immunotherapy as a Component of Multimodal Therapy in Earlier Stages of Lung Cancer: Rationale, Current Evidence, Key Trials, and Implications for Multidisciplinary Care
Naiyer Rizvi, MD
14 December, 2018
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Molecular Testing for EGFR Mutations in the Context of a Changing Treatment Landscape, Evolving Testing Options, and New Guidelines: What Pathologists Need to Know and Do
Lynette Sholl, MD
11 December, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
The Era of Immunotherapy in Stage III NSCLC: Exploring the Evidence and Practicalities of Integrating Checkpoint Inhibition Into the Multimodal Treatment Arsenal
Roy Decker, MD, PhD
7 December, 2018
Credits: 0.75 CME / MOC / CNE
Medical Learning Institute, Inc.
The Oncologist, Nurse, and Patient Partnership in AML: Multiple Perspectives on Integrating Targeted Therapy Into Care
Amir Fathi, MD
5 December, 2018
Credits: 1.00 MOC / CME
Medical Learning Institute, Inc.
Advances and Challenges in Refining the Use of Cancer Immunotherapies Through Biomarker Testing: Practical Guidance for Pathologists on the Front Lines of the Immuno-Oncology Revolution
Kurt Schalper, MD, PhD / Edward B. Garon, MD, MS
30 November, 2018
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Navigating the Complexities of Molecular Testing for EGFR Mutations to Guide Treatment Selection in Lung Cancer: Evidence, Practicalities, and Implications for Pathologists
Anjali Saqi, MD, MBA / Geoffrey R. Oxnard, MD
29 November, 2018
Credits: 1.50 CME / MOC / CE
Medical Learning Institute, Inc.
Improving Patient Outcomes With Cancer Immunotherapies Throughout the Lung Cancer Continuum: State of the Science and Implications for Practice
Edward Garon, MD, MS
22 November, 2018

Pages